Cases 71 - 80 of 110
Forest Laboratories, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv01210
Plaintiff:
Forest Laboratories, LLC , Forest Laboratories Holdings, Ltd. , Allergan USA, Inc. and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Counter_claimant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Counter_defendant:
Allergan USA, Inc. , Forest Laboratories Holdings, Ltd. , Forest Laboratories, LLC and others
Cause Of Action: 35 U.S.C. § 271
Kissei Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv01161
Plaintiff:
Kissei Pharmaceutical Co., Ltd. , Allegran Finance, LLC and Allergan Sales, LLC
Defendant:
Aurobindo Pharma Ltd. , Aurobindo Pharma U.S.A., Inc. and Aurobindo Pharma USA LLC
Counter_claimant:
Aurobindo Pharma U.S.A., Inc. , Aurobindo Pharma Ltd. and Aurobindo Pharma USA LLC
Counter_defendant:
Allegran Finance, LLC , Allergan Sales, LLC and Kissei Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Aurobindo Pharma U.S.A., Inc. et al
as 1:2017cv00824
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Aurobindo Pharma U.S.A., Inc. and Aurobindo Pharma USA LLC
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2017cv00483
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Shionogi Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00072
Plaintiff:
Shionogi Inc. and Andrx Labs, L.L.C.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
AbbVie Inc. et al v. Aurobindo Pharma Limited et al
as 1:2017cv00047
Plaintiff:
AbbVie Inc. and Abbvie Deutschland GMBH & Co. KG
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis AG et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv00048
Plaintiff:
Novartis AG , Novartis Pharmaceuticals Corporation , Mitsubishi Tanabe Pharma Corporation and others
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma USA, Inc., et al.
as 1:2016cv01299
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
